$16.02
-1.03-6.04%
In chiusura: Nov 19, 4:00 PM EST
$15.95
-0.07-0.44%
Post-mercato: 6:20 PM EST

Hims & Hers Health (HIMS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 9, 2026 | $0.03 | $0.06 | -50.0 % |
| Q2 | Aug 10, 2026 | $-0.37 | $-0.05 | -640.0 % |
| Q1 | May 11, 2026 | $-0.40 | $0.04 | -1100.0 % |
| Q4 | Feb 23, 2026 | $0.08 | $0.03 | 166.7 % |
Quarterly Revenue (Billions)
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 9, 2026 | $890.37M | $892.89M | -0.28 % |
| Q2 | Aug 10, 2026 | $753.21M | $722.14M | 4.30 % |
| Q1 | May 11, 2026 | $608.10M | $617.41M | -1.51 % |
| Q4 | Feb 23, 2026 | $617.82M | $618.03M | -0.03 % |
Hims & Hers Health (HIMS) ha pubblicato l'ultima guidance il novembre 9, 2026 per fiscal year 2026. La società ha previsto un fatturato pari a $3.13B - $3.15B per il periodo.
Rispetto alle previsioni precedenti, Hims & Hers Health ha modificato le sue previsioni di fatturato da un intervallo precedente di .
Hims & Hers Health ha pubblicato {{revenueDirection}} aggiornamenti delle previsioni tra il {{revenuePriorRange}} e il Hims & Hers Health. 32
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.06 | $-0.05 | $0.04 | $0.03 |
| Actual | $0.03 | $-0.37 | $-0.40 | $0.08 |
| Surprise | -50.0% | -640.0% | -1100.0% | +166.7% |
| Revenue | ||||
| Estimate | $892.9M | $722.1M | $617.4M | $618.0M |
| Actual | $890.4M | $753.2M | $608.1M | $617.8M |
| Surprise | -0.28% | +4.30% | -1.51% | -0.03% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.02 | $-0.07 | $-0.13 | $0.02 |
| Revenue | ||||
| Consensus | $908.3M | $906.7M | — | — |